Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.
about
T Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-AntitrypsinAcute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threatsMechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetesContext-Specific and Immune Cell-Dependent Antitumor Activities of α1-AntitrypsinNonhuman primate models of type 1 diabetes mellitus for islet transplantation.An immunosufficient murine model for the study of human islets.The current state of xenotransplantationStroke therapy: the potential of amniotic fluid-derived stem cells.Exploration of α1-antitrypsin treatment protocol for islet transplantation: dosing plan and route of administration.Xenotransplantation literature update, May-June 2013.Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?Diluted serum from calorie-restricted animals promotes mitochondrial β-cell adaptations and protect against glucolipotoxicity.Human α1-Antitrypsin Binds to Heat-Shock Protein gp96 and Protects from Endogenous gp96-Mediated Injury In vivoUnique CD8+ T Cell-Mediated Immune Responses Primed in the Liver.OX40 engagement depletes intratumoral Tregs via activating FcγRs, leading to antitumor efficacy.Point Mutation of a Non-Elastase-Binding Site in Human α1-Antitrypsin Alters Its Anti-Inflammatory Properties.
P2860
Q26829272-E5DBE2B8-13C0-4480-B9C2-E505D55AEC24Q26858837-F8A684DD-6FC9-48DD-9B34-72DB8B3EDA99Q26861561-7D96AB46-AC63-45CA-A215-7BB6CA971F48Q28817846-543108F8-6BAA-42DE-85E1-4E2484487F92Q34441658-EE724F3C-909C-4DDF-ABFF-9BB477F4019CQ34674640-8ED9BF78-528A-468E-A2B9-BA2CE3787B64Q35547701-5C68EA71-CABD-4D26-92A5-67361B9DB989Q36079327-852C074B-2C9E-4589-9CD0-322EB79C67D9Q37427900-79B9F066-5843-46CC-A15B-4C10E7D7CA59Q38124375-935F6BEF-93A7-4EF4-A682-89C6D5B36869Q38365800-12C1830B-51F2-496A-A31B-890D400F46E5Q38806386-A4AE8FC4-A8D0-4C94-98F0-9AE15B2D3717Q42152837-C9FFD53A-59D5-4021-A903-A359049274DBQ42429630-2C63AB42-8EE0-49AD-A954-D0F506D34F18Q44805706-FFB4D3D0-167B-42ED-8553-33684F623A00Q55438350-7D2C2F97-D6D2-45C8-A8C5-3DC8E64873F7
P2860
Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@ast
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@en
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@nl
type
label
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@ast
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@en
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@nl
prefLabel
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@ast
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@en
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@nl
P2093
P2860
P1433
P1476
Pancreatic islet xenograft sur ...... gle-dose anti-CD4/CD8 therapy.
@en
P2093
Boris M Baranovski
Efrat Ashkenazi
Eli C Lewis
Galit Shahaf
P2860
P304
P356
10.1371/JOURNAL.PONE.0063625
P407
P577
2013-05-22T00:00:00Z